TWiV 808: Clinical update #81 with Dr. Daniel Griffin
Sep 25, 2021•52 min•Ep. 808
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #81, Daniel Griffin discusses vaccine boosters, vaccination during pregnancy, mRNA vaccine comparison, J&J vaccine booster, EUA expansion for Lilly monoclonals, remdesivir reduces risk of hospitalization, and anticoagulation regimens.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Pfizer phase III results in 5-11 year olds (Pfizer)
- FDA authorizes booster (FDA)
- V-safe vaccine pregnancy registry (CDC)
- High antibody levels in cord blood (Am J Ob Gyn)
- mRNA vaccines compared (MMWR)
- Effectiveness of single shot J&J (medRxiv)
- J&J booster results (J&J)
- EUA expansion for Lilly mAbs (Lilly)
- Remdesivir reduces hospitalization risk (Gilead)
- DisCoVeRy on Remdesivir (Lancet)
- Prophylactic anticoagulant dosing (Eur Heart J)
- Letters read on TWiV 808
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android